Health & Fitness
Health and Fitness
Health and Fitness
Tue, January 6, 2009 ZymoGenetics to Webcast Presentation at J.P. Morgan Healthcare Conference
SEATTLE--([ BUSINESS WIRE ])--ZymoGenetics, Inc. (NASDAQ: ZGEN) announced today that Douglas E. Williams, Ph.D., Chief Executive Officer of ZymoGenetics, will provide an update on company activities at the 27th Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, January 14, 2009 at 3:30 p.m. Pacific Time.
A live webcast of the presentation can be accessed by going to: [ www.zymogenetics.com ]. The webcast will be archived for 30 days.
About ZymoGenetics
ZymoGenetics discovers and develops novel protein therapeutics that are based on the company's research and biological insights into key disease pathways. The Company developed and markets RECOTHROM® Thrombin, topical (Recombinant). Other product candidates span a wide array of clinical opportunities that include cancer, autoimmune and viral diseases. ZymoGenetics intends to commercialize product candidates through internal development, collaborations with partners, and out-licensing of patents from its extensive patent portfolio. For further information, visit [ www.zymogenetics.com ].
This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on the current intent and expectations of the management of ZymoGenetics.These statements are not guarantees of future actions and involve uncertainties that are difficult to predict. Except as required by law, ZymoGenetics undertakes no obligation to update any forward-looking or other statements in this press release, whether as a result of new information, future events or otherwise.
